Chicago Equity Partners LLC lifted its position in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 48.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,970 shares of the medical instruments supplier’s stock after buying an additional 3,905 shares during the quarter. Chicago Equity Partners LLC owned approximately 0.06% of ICU Medical worth $3,385,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Signition LP purchased a new stake in ICU Medical in the third quarter valued at approximately $251,000. Victory Capital Management Inc. purchased a new stake in ICU Medical during the third quarter worth approximately $2,995,000. State Board of Administration of Florida Retirement System grew its stake in ICU Medical by 1.6% during the third quarter. State Board of Administration of Florida Retirement System now owns 18,538 shares of the medical instruments supplier’s stock worth $5,242,000 after buying an additional 288 shares during the period. USA Financial Portformulas Corp purchased a new stake in ICU Medical during the third quarter worth approximately $541,000. Finally, Hussman Strategic Advisors Inc. purchased a new stake in ICU Medical during the third quarter worth approximately $1,414,000. Institutional investors and hedge funds own 73.51% of the company’s stock.
In other news, VP Virginia Ruth Sanzone sold 787 shares of the business’s stock in a transaction on Tuesday, August 28th. The shares were sold at an average price of $303.12, for a total transaction of $238,555.44. Following the transaction, the vice president now directly owns 1,367 shares of the company’s stock, valued at $414,365.04. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Thomas D. Mccall sold 11,133 shares of the business’s stock in a transaction on Friday, August 24th. The stock was sold at an average price of $302.56, for a total transaction of $3,368,400.48. Following the transaction, the vice president now directly owns 3,018 shares in the company, valued at $913,126.08. The disclosure for this sale can be found here. Over the last three months, insiders have sold 711,920 shares of company stock worth $202,651,956. Corporate insiders own 12.50% of the company’s stock.
NASDAQ ICUI opened at $232.01 on Friday. ICU Medical, Incorporated has a 52 week low of $196.33 and a 52 week high of $321.70. The firm has a market cap of $5.28 billion, a PE ratio of 42.03 and a beta of 0.65.
ICU Medical (NASDAQ:ICUI) last posted its earnings results on Thursday, November 8th. The medical instruments supplier reported $1.85 EPS for the quarter, topping analysts’ consensus estimates of $1.51 by $0.34. ICU Medical had a net margin of 5.93% and a return on equity of 12.78%. The business had revenue of $327.20 million for the quarter, compared to analysts’ expectations of $334.97 million. During the same period in the previous year, the company posted $1.12 earnings per share. The business’s revenue for the quarter was down 4.7% compared to the same quarter last year. Research analysts anticipate that ICU Medical, Incorporated will post 7.6 EPS for the current year.
ICUI has been the subject of several research reports. BidaskClub downgraded shares of ICU Medical from a “strong-buy” rating to a “buy” rating in a research note on Thursday, September 20th. TheStreet upgraded shares of ICU Medical from a “c+” rating to a “b+” rating in a research note on Monday, August 20th. ValuEngine downgraded shares of ICU Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, September 18th. Finally, Zacks Investment Research downgraded shares of ICU Medical from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 11th.
ICU Medical Company Profile
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Featured Article: Reverse Stock Split
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.